2.56
Nanovibronix Inc stock is traded at $2.56, with a volume of 132.56K.
It is down -16.07% in the last 24 hours and down -32.87% over the past month.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.
See More
Previous Close:
$3.05
Open:
$2.97
24h Volume:
132.56K
Relative Volume:
0.14
Market Cap:
$2.42M
Revenue:
$3.29M
Net Income/Loss:
$-3.09M
P/E Ratio:
-2.0813
EPS:
-1.23
Net Cash Flow:
$-2.46M
1W Performance:
-34.11%
1M Performance:
-32.87%
6M Performance:
-60.29%
1Y Performance:
-74.65%
Nanovibronix Inc Stock (NAOV) Company Profile
Name
Nanovibronix Inc
Sector
Industry
Phone
(914) 233-3004
Address
969 PRUITT AVE,, TYLER
Compare NAOV with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
NAOV
Nanovibronix Inc
|
2.56 | 2.42M | 3.29M | -3.09M | -2.46M | -1.23 |
![]()
ABT
Abbott Laboratories
|
131.93 | 228.81B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
100.05 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
377.46 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
88.86 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
72.05 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Nanovibronix Inc Stock (NAOV) Latest News
NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia - BioSpace
NanoVibronix expands distribution in Australia after study - Investing.com India
Healthcare Breakthrough: NanoVibronix Secures National Australian Distribution for UroShield Device - Stock Titan
NanoVibronix, Inc. SEC 10-K Report - TradingView
Why Nanovibronix Inc. (NAOV) Surged On Thursday? - MSN
10 Micro-, Small-Cap Firms Dominate Thursday’s Gains - Insider Monkey
NanoVibronix Inc (NASDAQ: NAOV) Gains 55.49% In Early Trade; What Lies Ahead? - stocksregister.com
NAOV Stock Earnings: NanoVibronix Reported Results for Q4 2023 - MSN
NanoVibronix (NAOV) Stock Is Skyrocketing: What's Going On? - Benzinga India
NanoVibronix (NAOV) Stock Surges In Pre-Market Trading Following A Positive Study - Stocks Telegraph
Top Premarket Gainers -March 17, 2025 at 07:39 am EDT - Marketscreener.com
Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga India
NanoVibronix announces UroShield health service study data published - TipRanks
NanoVibronix’s UroShield Study Published in Medical Journal - TipRanks
Breakthrough Study: Medical Device Slashes UTI Rates by 86% and Cuts Healthcare Costs - StockTitan
NanoVibronix announces reverse stock split - Medical Buyer
NanoVibronix announces reverse stock split By Investing.com - Investing.com Australia
NanoVibronix Announces 1-for-11 Reverse Stock Split - Nasdaq
NanoVibronix stock hits 52-week low at $0.3 amid market challenges - Investing.com
NanoVibronix stock hits 52-week low at $0.3 amid market challenges By Investing.com - Investing.com South Africa
NanoVibronix Announces Reverse Stock Split - citybiz
Nanovibronix announces reverse stock split - Marketscreener.com
NanoVibronix 1:11 Reverse Split Launches March 14Key Details for Shareholders - StockTitan
NanoVibronix shareholders approve reverse stock split By Investing.com - Investing.com South Africa
NanoVibronix shareholders approve reverse stock split - Investing.com
NanoVibronix stock plunges to 52-week low at $0.36 - Investing.com
NanoVibronix stock plunges to 52-week low at $0.36 By Investing.com - Investing.com Nigeria
NanoVibronix files to sell shares of Series G Convertible Preferred Stock, warrants - MSN
Oncolytics Biotech receives Nasdaq non-compliance notice - MSN
NanoVibronix Completes Merger with ENvue Medical Holdings - TipRanks
NanoVibronix Acquires ENvue Medical Holdings To Expand Medical Device Market Reach - Nasdaq
FDA Approves MED-EL’s Sonnet 3 Audio Processor for Cochlear Implants - MPO-mag
NanoVibronix Acquires Enteral Feeding Company ENvue - MPO-mag
NanoVibronix Acquires ENvue Medical Holdings - citybiz
NanoVibronix acquires enteral tech firm ENvue Medical - MSN
NanoVibronix Completes ENvue Medical Acquisition -February 14, 2025 at 10:54 am EST - Marketscreener.com
NanoVibronix completes acquisition of ENvue Medical - TipRanks
NanoVibronix acquires enteral tech firm ENvue Medical By Investing.com - Investing.com UK
NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp. - WICZ
Strategic Medical Tech Acquisition: NanoVibronix Takes Over Enteral Feeding Pioneer ENvue - StockTitan
Ascendis Pharma targets €200M SKYTROFA revenue and expands YORVIPATH globally in 2025 - MSN
Ocean Biomedical reports unregistered equity sales - MSN
IMUNON names Douglas Faller as chief medical officer - MSN
Pilot Phase Ends for NanoVibronix’s UroShield Study - MPO-mag
NanoVibronix Provides Year-End Business Update - ACCESS Newswire
NanoVibronix Announces Presentation of PainShield(R) to HCPCS Workgroup at CMS - ACCESS Newswire
NAOV’s 2023 Market Dance: Down -23.05% – Time to Invest? - The InvestChronicle
In the Green: MKDWELL Tech Inc (MKDW) Closes at 0.37, Up/Down -20.43 from Previous Day - The Dwinnex
Market Insights: Oncology Institute Inc (TOI)’s Notable Drop of -3.75, Closing at 0.85 - The Dwinnex
Nanovibronix Inc Stock (NAOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):